Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BLT ?4.8mm RC, SLA? 12mm, TiZr, Loxim: medical device reports filed with FDA

5,650 reports name it, 2019–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

5,650
device reports naming the brand
0% of all MAUDE reports · about 827 a year
1,037
reports, 12 months to August 2026
973 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

5,650 medical device reports received by FDA name the brand "BLT ?4.8mm RC, SLA? 12mm, TiZr, Loxim" (endosseous dental implant); the manufacturer given most often on reports is Institut Straumann; received from September 2019 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

1,037 reports arrived in the 12 months to August 2026, close to the 973 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (67.8%), loss of osseointegration (19.2%) and difficult to insert (1.5%). The patient problems coded most often are fibrosis, pain and tissue damage. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

092183Sep 2021: 41Oct 2021: 44Nov 2021: 56Dec 2021: 332022Jan 2022: 79Feb 2022: 28Mar 2022: 61Apr 2022: 67May 2022: 64Jun 2022: 69Jul 2022: 51Aug 2022: 74Sep 2022: 59Oct 2022: 101Nov 2022: 60Dec 2022: 572023Jan 2023: 88Feb 2023: 71Mar 2023: 63Apr 2023: 57May 2023: 72Jun 2023: 65Jul 2023: 50Aug 2023: 61Sep 2023: 75Oct 2023: 81Nov 2023: 84Dec 2023: 892024Jan 2024: 55Feb 2024: 70Mar 2024: 79Apr 2024: 64May 2024: 96Jun 2024: 74Jul 2024: 85Aug 2024: 77Sep 2024: 103Oct 2024: 114Nov 2024: 102Dec 2024: 862025Jan 2025: 79Feb 2025: 78Mar 2025: 83Apr 2025: 42May 2025: 0Jun 2025: 183Jul 2025: 57Aug 2025: 46Sep 2025: 72Oct 2025: 76Nov 2025: 89Dec 2025: 1002026Jan 2026: 80Feb 2026: 62Mar 2026: 85Apr 2026: 99May 2026: 102Jun 2026: 87Jul 2026: 84Aug 2026: 101

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

05031,0052019: 40320192020: 47920202021: 53220212022: 77020222023: 85620232024: 1,00520242025: 90520252026: 7002026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%5,650
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report77%4,352
Voluntary report0%0
User facility report0%0
Distributor report23%1,298
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate3,82867.8%62.8%
Loss of osseointegration1,08219.2%22.4%
Difficult to insertthe device was hard to insert841.5%0.4%
Fracturea broken bone140.2%1.6%
Difficult to removethe device was hard to remove80.1%0%
Separation failure70.1%0.1%
Unstable60.1%0%
Unintended movement50.1%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis1,84232.6%
Painpain, site not specified1,38324.5%
Tissue damage5359.5%
Inflammationinflammation4608.1%
Swelling/ edema3245.7%
Hemorrhage/blood loss/bleeding3045.4%
Fistula1793.2%
Abscessa collection of pus1783.2%
Hyperresponsive to stimuli1472.6%
Hypersensitivity/allergic reaction641.1%
Swellingswelling430.8%
Failure of implant420.7%
Sinus perforation340.6%
Numbnessnumbness330.6%
Inadequate osseointegration180.3%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBLT ?4.8mm RC, SLA? 12mm, TiZr, LoximProduct code DZEAll MAUDE reports
Reports5,6503,924,24126,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer77%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BLT ?4.8mm RC, SLA? 12mm, TiZr, Loxim reports

How many FDA reports name BLT ?4.8mm RC, SLA? 12mm, TiZr, Loxim?

5,650 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 1,037 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (67.8%), loss of osseointegration (19.2%), difficult to insert (1.5%), fracture (0.2%) and difficult to remove (0.1%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (77%) and distributor reports (23%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BLT ?4.8mm RC, SLA? 12mm, TiZr, Loxim was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.